[HTML][HTML] Lopinavir-ritonavir in SARS-CoV-2 infection and drug-drug interactions with cardioactive medications

S Agarwal, SK Agarwal - Cardiovascular drugs and therapy, 2021 - Springer
Lopinavir-ritonavir combination is being used for the treatment of SARS-CoV-2 infection. A
low dose of ritonavir is added to other protease inhibitors to take advantage of potent …

[HTML][HTML] Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications

S Agarwal, SK Agarwal - Cardiovascular Drugs and Therapy, 2021 - ncbi.nlm.nih.gov
Lopinavir-ritonavir combination is being used for the treatment of SARS-CoV-2 infection. A
low dose of ritonavir is added to other protease inhibitors to take advantage of potent …

Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications.

S Agarwal, SK Agarwal - Cardiovascular Drugs & Therapy, 2021 - search.ebscohost.com
Lopinavir-ritonavir combination is being used for the treatment of SARS-CoV-2 infection. A
low dose of ritonavir is added to other protease inhibitors to take advantage of potent …

[引用][C] Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications

S Agarwal, SK Agarwal - Cardiovascular Drugs and Therapy, 2020 - cir.nii.ac.jp
Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive
Medications | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications

A Shubham, SK Agarwal - Cardiovascular Drugs and Therapy, 2021 - search.proquest.com
Lopinavir-ritonavir combination is being used for the treatment of SARS-CoV-2 infection. A
low dose of ritonavir is added to other protease inhibitors to take advantage of potent …

[引用][C] Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications

S Agarwal, SK Agarwal - Cardiovascular Drugs and Therapy, 2020 - hero.epa.gov
Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive
Medications | Health & Environmental Research Online (HERO) | US EPA Jump to main content …

Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications.

S Agarwal, SK Agarwal - Cardiovascular Drugs and Therapy, 2020 - europepmc.org
Lopinavir-ritonavir combination is being used for the treatment of SARS-CoV-2 infection. A
low dose of ritonavir is added to other protease inhibitors to take advantage of potent …

[PDF][PDF] Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications

S Agarwal, SK Agarwal - 2020 - academia.edu
Lopinavir-ritonavir combination is being used for the treatment of SARS-CoV-2 infection. A
low dose of ritonavir is added to other protease inhibitors to take advantage of potent …

Lopinavir-ritonavir in SARS-CoV-2 infection and drug-drug interactions with cardioactive medications.

S Agarwal, SK Agarwal - 2021 - cabidigitallibrary.org
Lopinavir-ritonavir combination is being used for the treatment of SARS-CoV-2 infection. A
low dose of ritonavir is added to other protease inhibitors to take advantage of potent …

Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications

S Agarwal, SK Agarwal - Cardiovascular drugs and …, 2021 - pubmed.ncbi.nlm.nih.gov
Lopinavir-ritonavir combination is being used for the treatment of SARS-CoV-2 infection. A
low dose of ritonavir is added to other protease inhibitors to take advantage of potent …